The move comes just after a Delaware judge blocked a prominent Kindred shareholder’s motion to block the proposed acquisition at the end of March.
Officials expect to close the transaction this summer.
“We are pleased that the transaction with the consortium received the broad support of our stockholders in recognition of the robust process undertaken by the board to achieve maximum value. We look forward to completing the transaction in the coming months and delivering premium cash value to our stockholders,” said Kindred President and CEO Benjamin A. Breier.
More articles on transactions and valuations:
Penn Medicine aligns with 2 Trinity Health hospitals
US healthcare deals spur global M&A to hit 17-year record high in Q1 2018
2nd state entity OKs proposed Beth Israel Deaconess, Lahey Health merger
